Ernexa Therapeutics Inc. (ERNA) Revenue (2010 - 2024)
Ernexa Therapeutics' (ERNA) quarterly Revenue came in at $19000.0 in Q4 2024, down 61.22% YoY from $49000.0 in Q1 2024, and down 96.1% on a QoQ basis from $487000.0 in Q3 2024.
Ernexa Therapeutics Inc. (ERNA) Revenue (2010 - 2024) Analysis & Trends
Ernexa Therapeutics (ERNA) has 13 years of Revenue data on file, last reported at $19000.0 in Q4 2024.
- Quarterly Revenue fell 61.22% year-over-year to $19000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $600000.0 (up 500.0% YoY) and the FY2024 annual result came in at $600000.0, up 500.0% from the prior year.
- Revenue declined to $19000.0 in Q4 2024, from $487000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $2.4 million in Q1 2020 to a low of $19000.0 in Q4 2024.
- A 3-year average of $638444.4 and a median of $51000.0 in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2020 — Revenue sank 77.26% — and 2024, when it soared 854.9%.
- Tracing ERNA's Revenue over 3 years: stood at $1.2 million in 2020, then tumbled by 95.83% to $49000.0 in 2023, then tumbled by 61.22% to $19000.0 in 2024.
- The last three Revenue figures came in at $19000.0 (Q4 2024), $487000.0 (Q3 2024), and $47000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 487,000.00 |
| Jun 30, 2024 | 47,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 51,000.00 |
| Dec 31, 2020 | 1.18 Mn |
| Sep 30, 2020 | 1.48 Mn |
| Mar 31, 2020 | 2.39 Mn |
| Dec 31, 2019 | 5.17 Mn |
| Sep 30, 2019 | 4.58 Mn |
| Jun 30, 2019 | 5.23 Mn |
| Mar 31, 2019 | 4.83 Mn |
| Dec 31, 2018 | 5.92 Mn |
| Sep 30, 2018 | 6.00 Mn |
| Jun 30, 2018 | 5.65 Mn |
| Mar 31, 2018 | 5.76 Mn |
| Dec 31, 2017 | 5.30 Mn |
| Sep 30, 2017 | 5.20 Mn |
| Jun 30, 2017 | 5.55 Mn |